Latest Breaking News On - Director jeffrey scott riley - Page 1 : comparemela.com

Gain Therapeutics (NASDAQ:GANX) Given Buy Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Gain Therapeutics (NASDAQ:GANX – Free Report) in a report issued on Wednesday morning, Benzinga reports. HC Wainwright currently has a $9.00 target price on the stock. GANX has been the topic of a number of other reports. Chardan Capital reissued a buy rating and set a […]

Jeffrey scott rileySecurities exchange commissionGain therapeutics incGain therapeutics company profileGain therapeuticsFree reportGet free reportDirector jeffrey scott rileyExchange commissionGain therapeutics daily

Gain Therapeutics, Inc (NASDAQ:GANX) Sees Significant Growth in Short Interest

Gain Therapeutics, Inc. (NASDAQ:GANX – Get Free Report) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 149,600 shares, a growth of 8.3% from the March 31st total of 138,100 shares. Currently, 1.1% of the company’s shares are short sold. Based on an […]

Jeffrey scott rileyGain therapeutics company profileGain therapeutics incGain therapeuticsGet free reportDirector jeffrey scott rileyGain therapeutics dailyNasdaq ganx

HC Wainwright Reiterates Buy Rating for Gain Therapeutics (NASDAQ:GANX)

HC Wainwright Reiterates Buy Rating for Gain Therapeutics (NASDAQ:GANX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Jeffrey scott rileyGain therapeutics incSecurities exchange commissionGain therapeuticsFree reportChardan capitalGet free reportDirector jeffrey scott rileyExchange commissionGain therapeutics daily

Gain Therapeutics (NASDAQ:GANX) Receives Buy Rating from HC Wainwright

Gain Therapeutics (NASDAQ:GANX) Receives Buy Rating from HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Jeffrey scott rileyGain therapeutics incGain therapeutics company profileGain therapeuticsFree reportGet free reportDirector jeffrey scott rileyGain therapeutics daily

Gain Therapeutics, Inc (NASDAQ:GANX) Director Acquires $115,800 00 in Stock

Gain Therapeutics, Inc. (NASDAQ:GANX – Get Free Report) Director Jeffrey Scott Riley bought 30,000 shares of the firm’s stock in a transaction on Thursday, March 28th. The shares were purchased at an average price of $3.86 per share, for a total transaction of $115,800.00. Following the completion of the transaction, the director now owns 30,000 […]

Jeffrey scott rileyRoyal bankNewedge advisorsRenaissance technologiesDimensional fund advisorsGain therapeutics incSecurities exchange commissionGain therapeuticsGet free reportDirector jeffrey scott rileyExchange commissionStreet groupFund advisorsChardan capitalGain therapeutics dailyNasdaq ganx